Top Markets
Coin of the day
Beijing Bohui Innovation Biotechnology Group Co., Ltd. Beijing Bohui Innovation Biotechnology Group Co., Ltd.

Beijing Bohui Innovation Biotechnology Group Co., Ltd.

300318
Rank in Stocks #12214
Beijing Bohui Innovation Biotechnology Group Co., Ltd. is a Chinese enterprise... Beijing Bohui Innovation Biotechnology Group Co., Ltd. is a Chinese enterprise that manages the full spectrum of diagnostic product operations, from initial research and development through manufacturing, sales, and post-sale support. Their offerings include a variety of diagnostic tools such as the GenPlex microfluidic automated system for nucleic acid detection, immunofluorescence detection solutions, and products for analyzing human trace elements. Additionally, the company provides advanced chemical analysis instrumentation, featuring atomic fluorescence spectrometers, photometers, mass spectrometers, chip ion sources, microfluidic flow chemical analysis systems, and ICP spectroscopy equipment, along with vital consumables for life sciences. Founded in 2001, the company is headquartered in Beijing, China. It adopted its current name, Beijing Bohui Innovation Biotechnology Group Co., Ltd., in August 2021, having previously been known as Beijing Bohui Innovation Biotechnology Co., Ltd.
Share Price
$0.74920478
Market Cap
$612.03M
Change (1 day)
0.58%
Change (1 year)
-9.60%
Country
CN
Trade Beijing Bohui Innovation Biotechnology Group Co., Ltd. (300318)

Category

Revenue for Beijing Bohui Innovation Biotechnology Group Co., Ltd. (300318)
Revenue in Aug 2026 TTM: 0
According to Beijing Bohui Innovation Biotechnology Group Co., Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Beijing Bohui Innovation Biotechnology Group Co., Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$12.62B -
US
$6.02B -
NL
$15.74B -
AU
$2.23B -
US
- -
CH